VF
NEXI

Virtu Financial’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Virtu Financial’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,710
Closed -$10K – 2278
2022
Q4 		$10K Buy
+1,710
New +$21.3K ﹤0.01% 1389

Other funds holding NEXI

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Virtu Financial's NEXI Position: Q1 2023 in Review

Virtu Financial sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2023, closing a stake of 1,710 shares — an estimated $10K sold.

Virtu Financial first reported a position in NEXI in Q4 2022 and held it in 1 quarter. The position peaked at $10K in Q4 2022. 31 funds tracked by Wall St. Rank hold NEXI as of Q1 2023.

  • Virtu Financial reported no remaining NexImmune, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 1,710 NexImmune, Inc. Common Stock shares in Q1 2023, an estimated $10K.
  • Virtu Financial first reported a position in NexImmune, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Virtu Financial's NexImmune, Inc. Common Stock position peaked at $10K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.